STOCKHOLDERS' EQUITY

12 Months Ended

Dec. 31, 2024

Stockholders' Equity Note [Abstract]

STOCKHOLDERS' EQUITY

STOCKHOLDERS' EQUITY

Capital Stock

Our authorized capital stock consists of 250,000,000 shares of common stock, $0.001 par value per share, and 10,000,000 shares of preferred stock, $0.01 par value per share.

As of December 31, 2024, and 2023, there were 72,514,652 and 70,239,890 shares of common stock issued and outstanding, respectively. There were no shares of preferred stock issued and outstanding on either date.

Shares Repurchases

On May 24, 2022, the Company announced that the Board of Directors approved a new share repurchase program ("SRP") authorizing the Company to repurchase up to $50.0 million of its common stock. Pursuant to this authorization, the Company may repurchase shares of its common stock on a discretionary basis from time to time through open market purchases. The repurchase program has no expiration date and may be modified, suspended, or terminated at any time.

There were no share repurchases during the year ended December 31, 2024, and 2023. As of December 31, 2024, there was $38.7 million of the authorization remaining for future common stock repurchases under the SRP.

Accumulated Other Comprehensive Loss

Table 11.1: Details of Changes in Accumulated Other Comprehensive Loss by Category
	Foreign currency translation adjustment		Pension liability adjustment		Total
	(in thousands)
Balance as of December 31, 2022	$	(162)	$	107	$	(55)
Other comprehensive loss, net of tax	(5)		—		(5)
Balance as of December 31, 2023	(167)		107		(60)
Other comprehensive loss, net of tax	(8)		(61)		(69)
Balance as of December 31, 2024	$	(175)	$	46	$	(129)